Diffuse Midline H3K27-Altered Gliomas in the Spinal Cord: A Systematic Review
ConclusionsOutcomes for DMG-SCs are poor overall but appear to be favorable compared to intracranial DMGs. Despite the recent WHO 2021 grade 4 classification for all DMGs, given the differences in overall survival reported based on historical grading systems, future studies on DMG-SCs are needed to further define if DMG-SCs may represent a heterogeneous group of tumors with different prognoses.
Source: Journal of Neuro-Oncology - Category: Cancer & Oncology Source Type: research
More News: Brain | Brain Tumor | Cancer & Oncology | Chemotherapy | Databases & Libraries | Glioma | History of Medicine | Neurology | Neuroscience | Neurosurgery | Radiation Therapy | Science | Study | Temodar